ICOS ligand expression is essential for allergic airway hyperresponsiveness

Area of Science:

• Immunology
• Allergy Research
• Respiratory Medicine

Background:

• Inducible co-stimulator ligand (ICOSL) is a co-stimulatory molecule vital for T-cell responses.
• T(h)2 immune responses are central to allergic conditions like asthma.

Purpose of the Study:

• To investigate the role of ICOSL in allergic airway inflammation and hyperresponsiveness.
• To elucidate ICOSL's impact on immune responses in a mouse model of asthma.

Main Methods:

• Utilized ovalbumin (OVA)-induced asthma model in ICOSL knockout (KO) and wild-type (Wt) mice.
• Assessed lung eosinophil infiltration, histopathology, mucus production, and airway hyperresponsiveness.
• Analyzed serum antibody titers (IgG1, IgG2a, IgE) and T-cell cytokine production (T(h)1, T(h)2, T(h)17).

Main Results:

• ICOSL KO mice showed significantly reduced lung eosinophilia, inflammation, mucus, and airway hyperresponsiveness compared to Wt mice.
• Antigen-specific IgG1, IgG2a, and IgE antibody titers were lower in ICOSL KO mice.
• CD4(+) T cells from ICOSL KO mice produced less T(h)2 cytokines but more T(h)1 and IL-17 cytokines.

Conclusions:

• ICOSL plays a significant role in promoting allergic airway hyperresponsiveness.
• ICOSL enhances IgE antibody class switching and T(h)2 cytokine production.
• ICOSL diminishes T(h)17 responses and airway eosinophilia, contributing to asthma pathogenesis.